Introduction
Iron metabolism and immunity are closely interconnected (1, 2) . This is on the one hand due to divergent regulatory effects of the metal on immune cell proliferation (3) and on the effectiveness of cellular immune effector pathways (4) (5) (6) .
On the other hand, cytokines derived from T-cells and monocytes regulate cellular iron homeostasis by affecting the expression of proteins involved in the uptake and storage of the metal.
Pro-inflammatory cytokines such as TNF-, IL-1 or IL-6 directly stimulate the transcription and translation of the major iron storage protein ferritin, the latter by interfering with a so-called acute phase box (7, 8) . Moreover, cytokines also influence the posttranscriptional control of iron homeostasis by modulating the binding affinity of iron regulatory proteins (IRP-1 and IRP-2) to specific RNA stem loop structures, termed iron responsive elements (IRE), which are found within the 5' untranslated region of ferritin mRNA and within the 3' untranslated region of transferrin receptor (TfR) mRNA, the surface protein involved in the uptake of transferrin bound iron.
Activation of IRP binding to IREs is controlled by intracellular iron availability with IRP binding affinity being high when intracellular iron concentrations are low, thus resulting in stabilization of TfR mRNA while ferritin translation is reduced (for review see [9] [10] [11] . In murine macrophages cytokines, such as IFN-and LPS, can affect IRP binding and subsequently ferritin and TfR expression via stimulation of NO or H 2 O 2 formation which then activates IRP-1 activity by different yet not fully elucidated pathways (12) (13) (14) . Some of these IFN-mediated effects on iron homeostasis in activated murine macrophages are counter balanced by anti-inflammatory cytokines such as IL-4 or IL-13 (15) .
The pivotal role of cytokines to induce changes in iron homeostasis in vivo was underscored by the finding that application of TNF-to mice resulted in hyperferritinemia and iron retention within the reticuloendothelial system and the development of anemia (16) . However, the only.
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The recent identification of transmembrane iron transporters has widened our knowledge of cellular iron traffic. The divalent metal transporter-1 (DMT-1) is a transmembrane protein which is centrally involved in the absorption of ferrous iron from the duodenum and the intracellular delivery of iron to erythroid progenitor cells (18, 19) . As a collaborating counterpart to DMT-1 the protein ferroportin (also named IREG-1 or MTP-1) is able to export iron across the basolateral membrane of enterocytes and to donate the metal after being oxidized by a membrane bound ferroxidase to the circulation (20) (21) (22) . Changes in iron homeostasis such as iron deficiency or iron overload are paralleled by marked changes of DMT-1 and ferroportin expression (23) (24) (25) (26) (27) while mutations of DMT-1 and/or ferroprotin are associated with microcytic anemia or iron overload, respectively (19, 28) . Both, DMT-1 and ferroportin contain a single IRE within the untranslated regions of their mRNA, however, their functionality in order to induce posttranscriptional/translational regulation of DMT-1 or ferroportin mRNA expression is still under investigation (29, 30 ) .
The current study was undertaken to investigate the functional role of these transporters in human monocytes, their regulation by pro-and anti-inflammatory cytokines and the effects of such changes on TfR and non-TfR mediated uptake and retention of iron within activated monocytes.
Materials and Methods
Cell culture techniques. THP-1 and U937 cells were grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin, and 0.1 mg/ml streptomycin at 37°C in humidified air containing 5% CO 2 . Cells were seeded at a density of 3x10 6 per flask in 10 ml of culture medium, and were then stimulated with varying concentration of rhIFN -(from Life technologies), LPS (E.coli 055:B5 from Sigma, Munich, Germany) and/or rhTNF-(from Repro Tech) for 20 hours. In some experiments cells were pre-incubated with rhIL-10 (10ng/ml, only.
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Generation of a 32 P-labeled IRE probe and gel retardation assay. Cells were grown in the appropriate medium plus additives and treated as described above. After harvesting and washing, detergent cell extracts were prepared as described previously (31) . A 32 P-labeled IRE probe was generated as described (15) using T7 RNA polymerase and purified by gel electrophoresis (15% of 20:1 acrylamide/bisacrylamide; 6 M urea) followed by probe elution, phenol/chloroform extraction and ethanol precipitation. The DNA template had the sequence 5'-GGGATCCGTC CAAGCACTGT TGAAGCAGGA TCCCTATAGT GAGTCGTATT A-3'.
Approx. 15000 cpm of this transcript were incubated with 15 µg protein of each cellular extract at room temperature. After 20 minutes, heparin (final concentration 3mg/ml) was added for ten minutes and analysis of RNA/protein complexes was carried out by non-denaturating gel electrophoresis and subsequent autoradiography as described (31) .
RNA extraction and Northern blot analysis. Cells were stimulated for up to 24 hours as described above. Preparation of total RNA and Northern hybridization were then carried out as detailed elsewhere (5) . Briefly, RNA was prepared by the acid guanidinium thiocyanate-phenol-chloroform extraction. Ten µg of total RNA were separated on 1% agarose/2.2 M formaldehyde gels, and RNA was blotted on to Duralon-UV membranes (Stratagene, La Jolla, CA). After UV-crosslinking and prehybridization at 65°C, blots were hybridized overnight in 3xSSC, 0.1 % SDS, 0.1 % sodium pyrophosphate, 10 % dextran sulfate, 10x Denhardt's solution (0.2 % Ficoll 400, 0.2 % polyvinylpyrrolidone, 0.2 % bovine serum albumin), and 1 mg/ml of denatured salmon sperm DNA. After washing, filters were exposed for up to 4 days to XRP -5 X-ray films (Kodak, X-OMAT RP, Sigma) with intensifying screens at -80°C. Probes were labeled with [ -32 P]dCTP (DuPont New England Nuclear, Boston, MA) using the oligoprimer procedure. (26) using an AbiPrism 7700 Sequence detector (Perkin-Elmer, Vienna, Austria). In order to minimize intra-and inter-assay variability due to differences in PCR efficiency, FP1 and DMT1 quantities were normalized to the amount of ß-actin cDNA.
Western blot experiments:
Western blots were carried out as described in detail elsewhere (26) .
Briefly, protein extracts from cells were prepared using RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris HCl pH 8.0, 0.2 mM PMSF, 1 µg/ml pepstatin, 0.5 µg/ml leupeptin) and 10µg of total protein were used for immunoblotting. Blots were incubated with 0.5 µg/ml of mouse anti human TfR antibody (from Zymed) for 1 hour at room temperature and then stained with a horse radish peroxidase conjugated anti-mouse IgG antibody (Dako Inc.). 6 cells were then resuspended in 5 ml of this serum-free culture medium containing either 12.5 µg/ml of 59 Fe-labeled transferrin to study transferrin mediated iron uptake or with 5 µmol/L. 59 Fe-citrate (specific activity 6.7 mCi/ml) to investigate the uptake of non-transferrin bound iron (NTBI) into cells as described (32) .
Immuno-cytochemistry:
Cells were then incubated at 37°C for four hours, harvested, washed trice, transferred to fresh tubes and re-suspended in warm Hanks buffered solution. The cell pellet, culture supernatant and all washes were then quantified in a gamma-counter. Radioactivity in cells and supernatants was determined, and uptake expressed as ng Fe taken up per 10 6 cells per hour.
For iron release experiments cells treated with the appropriate additives for 20 hours were incubated with a 1:1 mixture of 59 Fe-labelled-transferrin and 59 Fe-ferric-citrate for three hours, then washed four times with pre-warmed serum-free culture medium, and the release of radio-labeled iron was then determined for up to three hours. After that, supernatants were saved, cells were lysed and the radioactivity of the supernatants and the cell pellets were counted by means of a gamma-counter.
only.
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The sum of radioactivity in the supernatant and of cells was named total cellular radioactivity and a the relative percentage of total radioactivity in the supernatant was calculated.
Statistical analysis: Calculation of statistical significances was carried out by Student's t-test. Fe-transferrin incorporation which is in accordance with the increased TfR surface expression observed under these conditions (compare Figures 1 to 3) .
Results

Effects of cytokines on TfR expression and on
Effects of cytokines on the expression of transmembrane iron transporters and on non-TfR mediated iron transport:
Since treatment of mice with pro-inflammatory cytokines is known to result in iron retention within the reticulo-endothelial system, and since pro-inflammatory cytokines only.
For and THP-1 cells from the culture medium which paralleled the effects of these cytokines on DMT-1 expression. Accordingly, pre-incubation with IL-10 prior to stimulation of cells with IFN-/LPS slightly reduced uptake of NTBI, however, this was still higher than in unstimulated controls ( Figure 7) . Interestingly, the relative changes in the uptake of NTBI were almost the same when studying iron uptake after one versus four hours (Figure 7) , although cellular iron levels after one hour estimated approximately 30% of that observed after four hours. The same applies to transferrin mediated iron uptake where the relative changes in iron acquisition were similar after exposition of cells to 59 Fe-transferrin for one or four hours, respectively (details not shown).. When comparing the amount of NTBI and TBI mediated iron uptake with iron release over a period of four hours we found that iron release estimated approximately 6.3% of NTBI mediated iron uptake and 24% of TBI mediated iron acquisition, respectively (compare Figures 3,7 and 8 ).
Discussion
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The data presented here demonstrate that iron uptake and release by monocytes are regulated at multiple steps which are differently affected by pro-and anti-inflammatory cytokines. Nonetheless, TfR expression appears to be also regulated at the post-translational level (17, (33) (34) (35) 37) , since TfR protein levels, TfR surface expression and TfR mediated iron uptake observed after single stimulation with IFN-, LPS or TNF-did not significantly differ from the control (Figures 1 and 2) .
Interestingly, IFN-/LPS treatment which is likewise the most appropriate model to study the effects of inflammation led to significant reduction of TfR expression and TfR mediated iron uptake which was reversed upon pre-incubation with IL-10. Possible mechanism underlying this observation include direct effects of the Il-10 on the endosomal uptake and re-circulation of TfR-transferrin-iron complexes or may be due to cytokine mediated regulation of the non-classical MHC-I protein HFE which affects the binding affinity of transferrin-iron to TfR and possibility also the endosomal iron release (for review see 38, 39) .
Second, the pro-inflammatory stimuli investigated in our study increased the uptake of NTBI into monocytes which may be due to up-regulation of DMT -1 mRNA and protein expression by the cytokines (Figure 5; 40) . The time course experiments demonstrating comparable relative levels of NTBI within cells following cytokine treatment indicate that cellular iron accumulation at these early time points (i.e. one and fours hours, Figure 7) is primarily a reflection of increased iron uptake.
Moreover, TNF-significantly increased DMT-1 expression as compared to controls but did not affect the uptake of NTBI. This suggests that DMT-1 mediated iron uptake may be further regulated by posttranslational modifications, e.g. via affecting the enzymatic activity of DcytB, a membrane bound ferric reductase linked to DMT-1 (41) . Although, DMT-1 mRNA bears an IRE within its 3' untranslated region (18) , cytokine mediated regulation of DMT-1 mRNA expression via IRE/IRP interaction may not play an important role in our setting since IRP binding affinities were not increased by cytokine treatment (Figure 1 ). Alternatively, it is possible that IFN-/LPS and IL-10 may affect other as yet known identified pathways for the uptake of molecular iron not linked to DMT-1 (42, 43) .
Third, we studied the expression of the transmembrane iron transporter ferroportin which has previously been identified as the protein being responsible for the export of iron from enterocytes (20) (21) (22) . From our data presented here it became evident that ferroportin is involved in only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From the release of iron from monocytes. Reduced ferroportin mRNA and protein expression resulted in a diminished iron release from cytokine stimulated monocytes which points to the gate-keeper function of ferroportin in controlling iron export/iron retention in monocytes. Ferroportin expression was dose-dependently down-regulated by LPS and IFN-, with a combination of both being most effective (Figures 5 and 6 ). This was paralleled by a significant reduction in iron release from THP-1 and U937 cells (Figure 8 For all experiments cytoplasmic DMT-1 mRNA levels were determined by quantitative lightcycler PCR. Values were corrected for the amount of ß-actin mRNA which was determined in parallel.
Results are shown as relative differences of the DMT-1/ß-actin cDNA ratio as compared to the unstimulated control (= 100%). Data are expressed as means+SD for three independent experiments each performed in triplicates. *, p<0.05 and **, p< 0.01 as compared to the control, respectively. In all experiments ferroportin mRNA expression was determined by quantitative light cycler PCR.
Values were then corrected for the amount of ß-actin cDNA which was determined in parallel.
Results are shown as relative differences of the ferroportin/ß-actin ratio as compared to the unstimulated control (= 100%). Data are expressed as means+SD for three independent experiments in each setting performed in triplicates. *, p<0.05 and **, p< 0.01 as compared to the control, respectively. only.
